Clinical Trial Update: Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of trabectedin and pioglitazone in myxoid liposarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dedifferentiated Liposarcoma
• Myxoid Liposarcoma
• Round Cell Liposarcoma

Drugs mentioned

• Actos (Pioglitazone)
• Yondelis (trabectedin)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Liposarcoma, Myxoid, Liposarcoma, Dedifferentiated | Phase 2 | Status: COMPLETED